BEAT Therapeutics

About BEAT Therapeutics

The startup develops DNA Damage Response (DDR) therapies that target aggressive cancers with high treatment resistance and poor survival rates. By enhancing the DNA repair mechanisms in cancer cells, the company aims to provide effective treatment options where conventional therapies have failed.

What does BEAT Therapeutics do?

The startup develops DNA Damage Response (DDR) therapies that target aggressive cancers with high treatment resistance and poor survival rates. By enhancing the DNA repair mechanisms in cancer cells, the company aims to provide effective treatment options where conventional therapies have failed.

Where is BEAT Therapeutics located?

BEAT Therapeutics is based in Porto, Portugal.

When was BEAT Therapeutics founded?

BEAT Therapeutics was founded in 2023.

Who founded BEAT Therapeutics?

BEAT Therapeutics was founded by Ângela Carvalho.

  • Ângela Carvalho - Co-founder/CEO
Location
Porto, Portugal
Founded
2023
Employees
7 employees
Looking for specific startups?
Try our free semantic startup search

BEAT Therapeutics

Score: 93/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

The startup develops DNA Damage Response (DDR) therapies that target aggressive cancers with high treatment resistance and poor survival rates. By enhancing the DNA repair mechanisms in cancer cells, the company aims to provide effective treatment options where conventional therapies have failed.

beattherapeutics.com1K+
Founded 2023 – Porto, Portugal

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (5+)

Ângela Carvalho

Co-founder/CEO